China Jo-Jo Drugstores, Inc. — Form 6-K Summary
Reporting period: Form 6-K furnished for June 2023 and dated June 16, 2023. The filing identifies the issuer as China Jo-Jo Drugstores, Inc., although the request metadata names Ridgetech Inc.
Business Context
The company is a Cayman Islands exempted company with principal executive offices in Hangzhou, Zhejiang Province, China. It files annual reports on Form 20-F.
Material Event
The company furnished a June 16, 2023 press release announcing that it received notification regarding failure to comply with Nasdaq’s minimum bid price requirement.
- The filing does not state the applicable bid-price threshold, the period of noncompliance, the deadline to regain compliance, or any potential impact on the company’s Nasdaq listing.
- The underlying press release, identified as Exhibit 99.1, is referenced but its substantive text is not included in the provided filing content.
Financial Metrics and Liquidity
The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, balance-sheet data, or other financial metrics.
Guidance, Outlook, Risks, and Unusual Items
The Nasdaq minimum bid price deficiency represents a potential listing and trading risk. The filing does not provide management guidance, remediation plans, a reverse-split proposal, an appeal status, or other commentary regarding the deficiency.
Key Facts to Verify
- Confirm the issuer identity, because the filing names China Jo-Jo Drugstores, Inc., not Ridgetech Inc.
- Review Exhibit 99.1 for the exact Nasdaq notice date, compliance deadline, required bid price, and available cure period.
- Determine whether the company subsequently regained compliance, appealed the notice, completed a corporate action, or faced delisting proceedings.
- Assess any resulting effects on share liquidity, trading status, and investor holdings.